Journal
International journal of radiation oncology, biology, physics
Publication Date
2-1-2018
Volume
100
Issue
2
First Page
427
Last Page
435
Document Type
Open Access Publication
DOI
10.1016/j.ijrobp.2017.10.019
Rights and Permissions
Anderson CM, Sonis ST, Lee CM, Adkins D, Allen BG, Sun W, Agarwala SS, Venigalla ML, Chen Y, Zhen W, Mould DR, Holmlund JT, Brill JM, Buatti JM. Phase 1b/2a Trial of the Superoxide Dismutase Mimetic GC4419 to Reduce Chemoradiotherapy-Induced Oral Mucositis in Patients With Oral Cavity or Oropharyngeal Carcinoma. Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):427-435. doi: 10.1016/j.ijrobp.2017.10.019. Copyright 2017 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-ncnd/4.0/). https://doi.org/10.1016/j.ijrobp.2017.10.019
Recommended Citation
Anderson, Carryn M; Sonis, Stephen T; Lee, Christopher M; Adkins, Douglas; Allen, Bryan G; Sun, Wenqing; Agarwala, Sanjiv S; Venigalla, Madhavi L; Chen, Yuhchyau; Zhen, Weining; Mould, Diane R; Holmlund, Jon T; Brill, Jeffrey M; and Buatti, John M, "Phase 1b/2a trial of the superoxide dismutase mimetic GC4419 to reduce chemoradiotherapy-induced oral mucositis in patients with oral cavity or oropharyngeal carcinoma." International journal of radiation oncology, biology, physics. 100, 2. 427 - 435. (2018).
https://digitalcommons.wustl.edu/open_access_pubs/8159
